GlassScriptPhysician profile
John A Mehnert
NPI 1619930922
$1,987.62
in general payments reported to CMS, 2019-2025
25 companies · $258 in 2025
The $258 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $123 · 2021: $133 · 2022: $398 · 2023: $150 · 2024: $295 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $702.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $562.26 | 2019-2025 | Stravix, Grafix Pl, Collagenase Santyl |
| Extremity Medical | $294.48 | 2022 | |
| Organogenesis INC. | $247.73 | 2019-2025 | Puraply, Novachor |
| Paratek Pharmaceuticals, INC. | $141.72 | 2020-2025 | Nuzyra |
| Biotissue Holdings INC. | $139.69 | 2024 | |
| Osiris Therapeutics INC. | $127.13 | 2019 | |
| Pfizer INC. | $75.75 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $54.89 | 2025 | |
| Kerecis Limited | $41.77 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Aroa Biosurgery Incorporated | $35.07 | 2019 | |
| Horizon Therapeutics Plc | $34.19 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $25.94 | 2022 | |
| Zyla Life Sciences, INC. | $25.08 | 2019 | |
| Averitas Pharma INC. | $19.57 | 2024 | Qutenza |
| Acera Surgical, INC. | $19.34 | 2025 | Restrata Wound Matrix |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $18.80 | 2025 | |
| Geistlich Pharma, North America, INC. | $18.22 | 2023 | Bio-Gide |
| Reapplix INC. | $17.57 | 2025 | 3c Patch Kit - Box |
| Solventum Corporation | $16.51 | 2025 | Activ.A.C. |
| Trice Medical, INC. | $15.00 | 2023 | |
| Baxter Healthcare | $12.79 | 2020 | |
| Bioventus LLC | $11.78 | 2019 | |
| Advanced Oxygen Therapy INC. | $11.33 | 2022 | |
| Melinta Therapeutics, LLC | $11.04 | 2019 | |
| Polarityte, INC. | $9.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mehnert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.